Sector News

Evonik launches sales process for both MMA and PMMA business

July 12, 2018
Chemical Value Chain

Evonik Industries has confirmed to CW that it has launched the sales process for its methyl methacrylates (MMA) and polymethyl methacrylate (PMMA) business.

The business operates 18 production sites. Barclays is advising on the divestment. Evonik hopes that by the end of the year it will have a clear idea as to who is interested, and perhaps a potential buyer. Information packages have been sent to both strategic buyers and private equity firms over the last few days, the company tells CW.

Evonik is the world’s second-largest producer of both MMA and PMMA. Its MMA capacity is about 600,000 metric tons/year and that of PMMA, sold under the Plexiglas trademark, about 400,000 metric tons/year. The MMA plants are located at Wesseling and Worms, Germany; Fortier, Louisiana; and Shanghai, China.

The company declined to comment on reports on Reuters that the business has annual sales of roughly €1.8 billion ($2.1 billion) and EBITDA of about €400 million, but sources tell CW that the business is very cyclical and that the revenue number for the combined operation, including MMA and PMMA, can vary between €1.5 billion and €1.8 billion. The company also says it is too early to say how much the business could fetch and that the number will depend on the scope that the potential buyer would be interested to include.

Evonik said last year that it was working to develop an ethylene-based process called LiMA to produce MMA. The technology is included in the divestment package. Prior to that, it developed a new MMA production process called Aveneer, which the company never commercialized. The Aveneer process is based on ammonia, methane, acetone, and methanol.

By Natasha Alperowicz

Source: Chemical Week

Related News

February 28, 2021

Borealis to invest in new RTO to reduce CO2 emissions at Porvoo polyolefins plant

Chemical Value Chain

This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.

February 28, 2021

Grace to acquire Albemarle’s fine chemistry business for $570 million

Chemical Value Chain

The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.

February 28, 2021

Solvay to carve out soda ash business

Chemical Value Chain

Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.

Send this to a friend